Globalising A.S. Watson – the Alliance Boots catalyst?
By
Brian Moore, Global retail consultant and CEO
of
EMR-NAMNEWS
Download a copy of this article
(Adobe PDF)
With
the acceptance of the KKR-Pessina bid for Alliance Boots, and the relative lack
of property sell-off options, it is probable that the takeover is stage one in
the formation of a global retail and wholesale giant customer for health &
beauty suppliers everywhere. As a result, A.S. Watson, the world’s No. 2 H&B
player, will need to accelerate the aggregation of its purchasing worldwide, and
speed up its acquisition programme in emerging markets.
However, even with
these changes, A.S. Watson will remain at a competitive disadvantage unless it
finds a way to develop a wholesale network for the group, and add retail
pharmacy to its offering in order to capitalise upon opportunities arising from
pharmacy deregulation throughout Europe. The acquisition of Celesio by Hutchison
Whampoa would present these opportunities in one move. With a market
capitalisation of €9bn, the probable purchase price of €10bn would be well
within Hutchison’s ability to pay, and given the nature of the sector and
structure of the market, it is unlikely that any realistic competing bids would
emerge, presuming that the competition authorities would prevent an approach by
Alliance Boots.
Market changes of
this nature would have major implications for suppliers everywhere. On the one
hand, aggregation of A.S. Watson’s buying function for its 16 retail chains,
comprising 7,200 outlets in 36 countries, would be combined in one buying unit,
in order to avail of scale economies. In practice, this means that it would be
possible for A.S. Watson to compare local prices and terms by channel for
individual suppliers. As a result, suppliers that have pricing and terms
disparities across territories would be vulnerable to demands to supply at the
lowest price and best terms in countries and regions.
This will have a
fundamental impact upon trade prices and credit given by H&B suppliers. For
instance, a 2% difference between trade prices on a given product in adjoining
countries is sufficient for a third party trader to make a profit, even more in
the case of a retail chain with stores in each country. The scale of potential
terms disparities can be assessed through an examination of average credit
periods across Europe. Retailers in the UK typically pay their suppliers in 30
days, those in France within 58 days, Italy in 90 days, whilst Greek suppliers
have to wait up to 150 days on average for their money. Suppliers should
therefore conduct ‘what ifs’ on possible demands from A.S. Watson for credit
terms matching those of the country that are most advantageous to the retailer.
Whilst A.S. Watson
will undoubtedly make savings on buying, it will also have to compete directly
with Alliance Boots via in-store initiatives. This may partly explain the focus
upon in-store developments currently underway in Superdrug, its UK format.
Suppliers should anticipate the spread of the Superdrug in-store initiatives
throughout the A.S. Watson estate, and make plans to integrate their brand
strategies with those of the retailer, in the aisle. This means finding a
balance between the new Superdrug initiatives and A.S. Watson’s basic retail
strategy that capitalises upon a supplier’s brand positioning, and a realistic
assessment of how an aggregated player will compete with the new Alliance
Boots...
Hutchison already
have plans to increase their penetration of India and China, where they would
automatically have a short-term advantage over Alliance Boots. Meanwhile, they
would have to identify opportunities in the Americas to match KKR’s ability to
acquire wholesalers in South America and possibly Walgreen in the US. To this
should be added KKR’s global reach and their ability to raise appropriate
finance in assembling a truly global H&B operation involving most world markets.
However, by acquiring Celesio, A.S. Watson would make major steps forward in
extending its ability to capitalise upon a wholesale network to exploit prices
and terms disparities amongst suppliers across Europe, by physically moving
product from country to country. It is important that suppliers match these
moves by A.S. Watson by seeking to minimise prices and terms disparities across
territories.
Another advantage
of a Celesio acquisition would be in gaining access to the wave of pharmacy
deregulation moving through Europe via ownership of Celesio retail, and
indirectly via the wholesaler’s retail customers. Moreover, diversifying into
wholesaling and pharmacy would present very little difficulty for a group that
has managed to combine businesses in ports and related services,
telecommunications, property and hotels, retail and manufacturing, and energy
and infrastructure in a company with one of the highest rated stock in the
world.
Finally, the
combination of the New Alliance Boots and A.S. Watson Global represents a unique
opportunity for H&B suppliers to realistically globalise their retail
strategies, before these customers do it on their behalf…..
See our
follow-up paper on 'managing the changes' »

Date
article published: 02/05/2007